Comparing overdose mortality associated with methadone and buprenorphine treatment.
about
The utility of medico-legal databases for public health research: a systematic review of peer-reviewed publications using the National Coronial Information SystemNephrotoxicity of methadone: a systematic reviewOpioids in pregnancy and neonatal abstinence syndromeMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesPharmacological maintenance treatments of opiate addiction.Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study.New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Out-of-hospital mortality among patients receiving methadone for noncancer pain.Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.A conjugate vaccine attenuates morphine- and heroin-induced behavior in ratsBuprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and WalesBuprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.Illicit opioid intoxication: diagnosis and treatment.Impact of hepatitis C status on 20-year mortality of patients with substance use disorders.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatmentNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Adoption of medications in substance abuse treatment: priorities and strategies of single state authoritiesDynamic vaccine blocks relapse to compulsive intake of heroin.Counselor training and attitudes toward pharmacotherapies for opioid use disorder.Clinician beliefs and attitudes about buprenorphine/naloxone diversionPrevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.Probuphine® (buprenorphine implant): a promising candidate in opioid dependence.Effect of buprenorphine dose on treatment outcome.Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoBuprenorphine treatment for narcotic addiction: not without risks.Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study.Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment.Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?Favorable mortality profile of naltrexone implants for opiate addiction.Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012.Use and misuse of opioid replacement therapies: a Queensland study.Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study.
P2860
Q24288869-65758603-8809-4990-AEFE-BAE61D988B30Q28075979-D01D9975-14C0-4792-9F10-B9075DB11D90Q28082706-1DB71024-92D1-4DC0-AE76-CE65FA31E07FQ30234647-D1EDFF64-189B-4B86-B6FB-E2DB2EEF6867Q33582080-870EA3B2-559E-4272-A8E0-EADF67D6D5F9Q33688813-D1EED3EE-9899-47E7-856A-B4EFEB56D799Q33768352-32255C38-A657-46AE-986C-6D3E07642703Q34952233-D9B5E752-E1E5-4713-A6DD-B564867C79A3Q35137858-BB4F3067-4CE4-4983-8931-17A1AD057651Q35160035-68474C49-4011-4036-86AE-D5E5C3427D8DQ35224297-E111E9E9-ED6A-4509-A66A-AC13D706CAEDQ35228546-61D8FC3E-7C74-4420-8A17-BA5E0EF9E14DQ35675636-845BE3F8-D9D5-4860-A3E4-638DAE959B84Q35863900-993D5ECB-A6CA-4E69-AD24-FD1C5FE33C33Q36138964-ED7487D6-9747-4FD9-8F62-4389387E08A4Q36354119-674312D6-08AE-4086-92C5-3EEDA3FA6856Q36364490-52EA332F-C4BA-48EB-A2B3-F39385379276Q36730570-EAB6007C-9955-4174-B220-407582247AC8Q36806539-23CD149C-EAB4-4771-BF65-A5C6DA42A61EQ36895574-4C00D3F6-083C-4721-832E-738D65BF90E2Q36934945-955BBFEC-93C4-4337-AC49-94A689B1E0D5Q37241381-44D99874-AD6C-4605-AFCE-38C4A1E9B11EQ37248672-2E09AC1B-583C-4719-AFB8-949716200E21Q37281750-47D129A6-7FE8-48BD-873B-18ABF34B6D0DQ37565076-A53EE8DF-6F62-4312-88B0-D4DE5CE1685DQ37587221-F41CA1D0-9486-4D4D-929D-1AA8E9B52025Q37705253-F03EE37E-86C7-468D-AC48-B990000E0DC0Q37987271-2DBAC21A-E235-45AC-950C-7A28FAD99522Q38127854-0DB2A538-CFE2-4403-B3D8-4C3B5033ADD5Q38575591-81CB6B02-2D98-4CEC-85B8-65E39457EAC8Q39359619-E642E3B8-FDF0-4BF7-BA28-E06F67B64756Q40283005-94F97A61-BF9A-489E-B365-235C36FB3D5EQ40367486-FDB254EE-FD3B-4647-845B-868B75700BF3Q40669150-73609C65-3F0E-4218-9CAE-B1D7AF137F5FQ40991270-0C490ADC-3A55-48CF-9729-85FEA77C42C4Q43066207-EDCDE45D-1CF0-457D-BB15-32D961BE1347Q43100374-BCA11B03-9222-4B4D-A86C-109ECA60C9C8Q43660554-187D6AA7-A0EC-45BD-9BFD-313F2579F784Q44332368-B7301B4A-327C-4C4A-839B-E803507677F0Q44337239-6B4CED42-1FB5-4A37-8784-3E03D9AAD029
P2860
Comparing overdose mortality associated with methadone and buprenorphine treatment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@ast
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@en
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@nl
type
label
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@ast
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@en
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@nl
prefLabel
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@ast
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@en
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@nl
P2093
P1476
Comparing overdose mortality associated with methadone and buprenorphine treatment.
@en
P2093
Anne Lawrance
Bethany Butler
James R Bell
Pia Salmelainen
Robert Batey
P356
10.1016/J.DRUGALCDEP.2009.03.020
P577
2009-05-13T00:00:00Z